A pharmacokinetic study of intramuscular (i.m.) parecoxib sodium in normal subjects. (Record no. 11504052)

MARC details
000 -LEADER
fixed length control field 01457 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514011729.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200202s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0091-2700
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1177/00912700122012607
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Karim, A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20020214
245 00 - TITLE STATEMENT
Title A pharmacokinetic study of intramuscular (i.m.) parecoxib sodium in normal subjects.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of clinical pharmacology
Date of publication, distribution, etc. Oct 2001
300 ## - PHYSICAL DESCRIPTION
Extent 1111-9 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Analysis of Variance
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Inflammatory Agents, Non-Steroidal
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Area Under Curve
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclooxygenase Inhibitors
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Injections, Intramuscular
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Isoxazoles
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfonamides
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Laurent, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Slater, M E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kuss, M E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Qian, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Crosby-Sessoms, S L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hubbard, R C
773 0# - HOST ITEM ENTRY
Title Journal of clinical pharmacology
Related parts vol. 41
-- no. 10
-- p. 1111-9
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1177/00912700122012607">https://doi.org/10.1177/00912700122012607</a>
Public note Available from publisher's website

No items available.